Innovations In Health Care Financing And Service Delivery: Making Malaria Treatment Available Washington, DC December 8 (4:00-6:30 PM) and December 9 (9:00 AM-5:15 PM), 2011
"Innovations in Financing and Service Delivery: Making Malaria Treatment Available" will provide a forum to critically review and discuss the emerging evidence on novel ways to finance and deliver access to the treatment of malaria as well as ways to strengthen the quality of fever case management in both the public and private sectors.
The event aims to:
Critically review and discuss results and lessons from country experiences in innovations in the financing and delivery of first-line malaria treatment, the introduction of RDTs (or laboratory diagnosis), and the resulting need for treatment of non-malaria fevers. Policy makers will be informed of the most current and best technical evidence in these areas.
Provide a forum for international agencies active in global malaria control to take a stock of current knowledge (including pipeline projects), discuss views, and respond to clients’ comments and needs.
Identify critical evidence gaps to focus research.
Catalyze further knowledge-sharing and evaluation across malaria-endemic countries.
Leverage existing, and develop new, strategic partnerships for impact evaluation in malaria control (including joint evaluations and co-funding).
Four areas are proposed:
Review progress towards achievement of stated objectives—including an increase in the affordability, availability and accessibility of ACTs, as well as the adoption of sustainable financing for fever and malaria treatment at the national level.
Discuss the success of different approaches to making quality ACTs more accessible through both public and private sectors.
Focus on fever treatment as an integrated issue, including malaria diagnosis, malaria treatment, and treatment of non-malaria fevers.
Explore the contribution of impact evaluation to program design and policy decisions and improvements that can be made to increase its effectiveness.
The event aims to increase the impact of robust evaluations on policy making by reaching a critical target audience, which includes:
Malaria-endemic country government representatives.
Senior World Bank Officials.
Funders, e.g., USAID, DFID, and other bilateral agencies.
Senior researchers (in-country and from external institutions) of ongoing or recently completed country evaluations.
Country project managers (task team leaders) whose efforts are critical in ensuring the success of these interventions and evaluations.
"Making Malaria Treatment Available: Innovations in Financing and Service Delivery" will start at 4pm on Thursday, December 8th and continue through 5pm on Friday, December 9th.
Thursday, December 8 (4:00 pm – 5:30 pm) – Opening Plenary and Welcome Reception On the evening preceding the one-day research conference, a welcome reception will be held in downtown Washington, DC. This will follow an opening plenary session featuring:
A lecture by Professor Kenneth Arrow, Nobel Laureate in Economics and Emeritus Professor, Stanford University
A Question and Answer Session following the lecture, co-moderated by Maryse Pierre-Louise (Lead Health, Nutrition and Population Specialist, World Bank) and Jed Friedman (Senior Economist, Development Economics Research Group, World Bank)
Friday, December 9 (9:00 am-5:15 pm) – Research Conference and Policy Panel Friday will feature an opening lecture by Ramanan Laxminarayan (CDDEP) and presentations on the first year of the AMFm on financing expanded access to ACTs in the public and private sectors. Researchers will present recently completed and ongoing analytical work to an audience of technical and operational specialists. Assessments by ACTwatch, and work carried out with the support of MIEP (DIME/SIEF), AMFm, CDDEP, and CHAI, and other partners will be discussed.
The conference will conclude with a policy panel to discuss the implications of key results on malaria treatment policies. This discussion will be open to the public.
Thursday, December 8, 2011
VENUE: Preston Auditorium and MC Atrium
16:00 – 17:30
Opening Remarks: Justin Yifu Lin, Sr. Vice President and Chief Economist, World Bank
A lecture by Professor Kenneth Arrow, Nobel Laureate in Economics and Emeritus Professor, Stanford University, California: "Seven years after 'Saving Lives, Buying Time' - New Challenges for Financing Malaria Diagnosis and Treatment" Abstract | Presentation
A Question and Answer Session following the lecture, co-moderated by Maryse Pierre-Louise (Lead Health, Nutrition and Population Specialist) and Jed Friedman (Senior Economist, Development Economics Research Group) Abstract | Presentation
The research conference will consist of four thematic panels (three on research, one on policy). Research panels will consist of three to five study-specific presentations, each of which will last a maximum of twenty minutes, and will be followed by a 10-minute Q&A. The policy panel will discuss the implications of key results for malaria treatment policies and identify the priority knowledge gaps that need to be investigated.
Welcome Axel van Trotsenburg, Vice President, Concessional Finance & Global Partnerships, World Bank. Watch Video.
9:15 – 10:30
Opening Lecture and Global Case Study
"The Global Context for Financing Delivery Innovations in Fever Case Management and Malaria Treatment" by Ramanan Laxminarayan, CDDEP [Dr. Laxminarayan will offer his views on the current state of access to malaria treatment and on recent innovations that have been proposed to expand access to effective first-line antimalarials.] Abstract | Presentation | Video
"Frontiers of financing for access: the first year of the Affordable Medicines Facility-malaria" by Olusoji Adeyi, The Global Fund. [Dr. Adeyi will present achievements, challenges and lessons from the AMFm, an innovation in the architecture of development assistance to finance malaria treatments in the private and public sectors.] Abstract | Presentation | Video
"Balancing access and quality of care: fever case management in a changing malaria epidemiological environment" by Bruno Moonen, CHAI. Abstract | Presentation | Video
10:45 – 11:00
11:00 – 12:00
Short Presentations and Discussion Panel I: “Modes of access”
Moderator:Peter Lanjouw, Research Manager, World Bank
Uganda: Feasibility of introducing RDTs in the private sector (Gunther Fink, Harvard School of Public Health) Abstract | Presentation | Video
Kenya: Introducing subsidized ACTs and RDTs in the private sector (Jessica Cohen, Harvard School of Public Health Abstract | Presentation | Video
Kenya: Increasing access to diagnostics through the public sector (Willis Akhwale, Department of Disease and Control Prevention, Kenya) Abstract | Presentation
14:05 – 14:20
14:20 – 15:00
Short Presentations and Panel III: “Prices and availability of ACTs and RDTs”
Moderator:Daniel Kress, Bill & Melinda Gates Foundation
Got ACTs? Availability, price, market share and provider knowledge of antimalarial medicines in public and private sector outlets in malaria-endemic countries (Kate O'Connell, ACTwatch) Abstract | Presentation
ACT pricing in Phase 1 AMFm countries: Health Action International (Christa Cepuch, Health Action International) Abstract | Presentation
15:00 – 15:30
Potential research priorities for funding (brief remarks by potential financiers)
15:30 – 17:00
Policy Panel: “Innovation, implementation, and scalability – How can policies strengthen access to malaria treatment and improve the quality of fever case management?”
The panel will provide an opportunity to agree on a short list of current policy priorities and operational challenges that would benefit from further evaluation and to discuss which existing policies should be recommended for scale-up.
Moderator:Arianna Legovini, Head of the Development Impact Evaluation Initiative, World Bank
Panelists: Muhammad Pate, Minister of State, Federal Ministry of Health, Nigeria Bonface Fundafunda, Manager, Drug Supply Budget Line, Zambian Ministry of Health Willis Akhwale, Head, Department of Disease and Prevention Control, Republic of Kenya Olusoji Adeyi, Director, AMFm, The Global Fund David Schellenberg, Professor, London School of Hygiene and Tropical Medicine Michael Lynch, MD, MPH, Global Malaria Program, World Health Organization
17:00 – 17:15
Brief closing remarks "What have we learned? Key takeaways from Innovations in Financing and Service Delivery: Making Malaria Treatment Available"Arianna Legovini, DIME